ÂÜÀòÂÒÂ×

Jolyon Faria is a seasoned data science professional with extensive experience in the oncology domain, currently serving as a Data Science Director (Real World Evidence) at AstraZeneca since February 2018. Jolyon's work primarily involves strategic and targeted projects that support drug development through the analysis of real-world evidence and clinical trial data, with a strong focus on multimodal analysis and understanding heterogeneous treatment effects. Previously, Jolyon held various leadership roles in data science and machine learning within AstraZeneca's Oncology Data Science team, contributing significantly to lung cancer research. Jolyon's background includes positions as a Principal Data Scientist, Data Scientist, and Computational Biologist at notable companies such as Genomics plc and e-Therapeutics PLC, as well as academic experience as a post-doctoral researcher at Princeton University and a PhD in Biology from the University of Leeds. Education includes a Master's degree in Applied Statistics from the University of Oxford.